On this page · 5 sections→
Where the EU money came from
Funding by EU programme. Amounts are Hgbeyond Materials Sicence SL's own share of each project, not the project's full budget.
- Horizon 2020€14k · 3 projects
Projects
3 EU-funded projects, newest first. Each links to the official record.
- ORBITALPartner
Ocular Research By Integrated Training And Learning
Horizon 2020 · 2019–2024 · Project on CORDIS ↗
- IT-DED3Partner
Integrated Training in Dry Eye Disease Drug Development (IT-DED3)
Horizon 2020 · 2018–2022 · Project on CORDIS ↗
- 3D NEONETPartner
Drug Discovery and Delivery NEtwork for ONcology and Eye Therapeutics
Horizon 2020 · 2017–2022 · Project on CORDIS ↗
€14ktheir share
Works most with
Organisations that shared the most EU projects with this one. A good starting list for consortium partners.
- University College Dublin, National University of Ireland, DublinIreland · 2 shared projects
- The Queen'S University of BelfastUnited Kingdom · 2 shared projects
- Universidad Complutense de MadridSpain · 2 shared projects
- South East Technological UniversityIreland · 2 shared projects
- Universidad de ValladolidSpain · 2 shared projects
- Ocupharm Diagnostics SLSpain · 2 shared projects
- Institut National de la Sante et de la Recherche MedicaleFrance · 1 shared project
- Karlsruher Institut Fuer TechnologieGermany · 1 shared project
- The Provost, Fellows, Foundation Scholars & the Other Members of Board, of the College of the Holy & Undivided Trinity of Queen Elizabeth Near DublinIreland · 1 shared project
- The University of BirminghamUnited Kingdom · 1 shared project
- Universiteit AntwerpenBelgium · 1 shared project
- University of GalwayIreland · 1 shared project
- Sorbonne UniversiteFrance · 1 shared project
- Universidade Nova de LisboaPortugal · 1 shared project
- Ita-Suomen YliopistoFinland · 1 shared project
- Universidad de Santiago de CompostelaSpain · 1 shared project
Fields it works in
Research fields recorded on its Horizon projects.
- breast cancer
- confocal microscopy
- diabetes
- drug discovery
- gene therapy
- medicinal chemistry
- nanotechnology
- ophthalmology
- pharmacokinetics
- prostate cancer
- retinopathy
Is this your organisation?
Claim it with an EUACC listing (€39 once, reviewed by our editors): add what you build, your team and what you are looking for. We pre-fill it from your EU records. Listed companies reach investors through our newsletter and get matched to new EU calls first.
Claim this profile →Source: CORDIS (Horizon Europe, Horizon 2020, FP7) and the EU Funding & Tenders Portal (other EU programmes), matched by the EU registration number (PIC). Past participation does not mean the organisation is open to new partnerships.